Generic Name: Mylotarg for Acute Myeloid Leukemia ()
Mylotarg for Acute Myeloid Leukemia Reviews
"This medicine should be taken off the market. It caused more harm than good. My mother died because of incompetent doctors and Mylotarg. Nothing was changed about the ingredients/composition of this medicine after the FDA approved it to be brought BACK on the market after being taken off for TEN years. It was taken off because it killed more than it saved. Just like it is still doing. The only thing about this medicine that changed when it was brought back in late 2017 was the dosage and how it is administered."
"This is a medicine suggested for my sister who has only a few weeks to live. Will know tomorrow if Dr goes through with this. So scary. He did mentioned about it being taken off the market and now back available. How does one choose?"
More about Mylotarg (gemtuzumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD33 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
- Mylotarg drug information
Professional resources
- Mylotarg prescribing information
- Gemtuzumab (AHFS Monograph)
Related treatment guides
- Acute Myeloid Leukemia
